Lower respiratory tract infection cost-effectiveness of therapy
Lower respiratory tract infection Microchapters |
Differentiating Lower respiratory tract infection from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Lower respiratory tract infection cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Lower respiratory tract infection cost-effectiveness of therapy |
FDA on Lower respiratory tract infection cost-effectiveness of therapy |
CDC on Lower respiratory tract infection cost-effectiveness of therapy |
Lower respiratory tract infection cost-effectiveness of therapy in the news |
Blogs on Lower respiratory tract infection cost-effectiveness of therapy |
Directions to Hospitals Treating Lower respiratory tract infection |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Cost-Effectiveness of Therapy
Lower respiratory tract infections place a considerable strain on the health budget and are generally more serious than upper respiratory infections. Since 1993 there has been a slight reduction in the total number of deaths from lower respiratory tract infection. However in 2002 they were still the leading cause of deaths among all infectious diseases accounting for 3.9 million deaths worldwide and 6.9% of all deaths that year.